
Real-time regulatory updates from DEA, DOJ, FDA, CMS, and all 50 state medical boards — curated and analyzed by AI, reviewed by compliance experts. The only source you need to stay ahead of healthcare regulation changes.
192 articles published · Page 1 of 13
This article clarifies the complex DEA registration requirements for telehealth providers who prescribe controlled substances, particularly when crossing state lines. It addresses the implications of the Ryan Haight Act, the expiration of COVID-19 PHE waivers, and the DEA's proposed rules for prescribing controlled medications via telemedicine.
State chiropractic boards are increasingly issuing guidance and regulations on the use of telehealth for chiropractic care, including initial consultations, follow-up visits, and remote patient management. These regulations often define what services are permissible via telehealth, require patient consent, and specify documentation standards, impacting how chiropractors can integrate virtual care into their practices.
Iowa maintains a strict Corporate Practice of Medicine (CPOM) doctrine, prohibiting corporations and non-licensed entities from employing physicians or controlling medical decision-making. This significantly impacts the permissible business structures for telehealth providers, medspas, and other healthcare businesses operating in the state, requiring careful adherence to professional corporation models or management service organization (MSO) arrangements that respect professional independence.
Direct-to-consumer (DTC) telehealth weight loss brands face significant compliance challenges in states with strict Corporate Practice of Medicine (CPOM) doctrines. These laws prohibit corporations from employing physicians or controlling medical practices, requiring careful structuring to ensure physician independence and prevent fee-splitting.
The District of Columbia has specific regulations governing the establishment of a valid provider-patient relationship via telehealth, which is a prerequisite for prescribing. Practitioners must adhere to these standards, including a real-time, interactive audio-visual examination, to ensure compliance and avoid potential regulatory violations. Understanding these rules is crucial for any healthcare business operating or expanding telehealth services in DC.
The Centers for Medicare & Medicaid Services (CMS) has continued to expand the list of services eligible for Medicare reimbursement when furnished via telehealth, along with broadening the types of providers who can deliver these services. These updates reflect a sustained commitment to integrating telehealth into the permanent healthcare landscape, moving beyond pandemic-era flexibilities.
Direct-to-Consumer (DTC) telehealth weight loss brands face significant compliance challenges in states with strict Corporate Practice of Medicine (CPOM) doctrines. These laws prohibit corporations from employing physicians or dictating medical decisions, necessitating careful structuring to avoid illegal fee-splitting and ensure physician independence.
This article clarifies the evolving DEA regulations regarding the prescribing of controlled substances via telehealth, particularly for providers operating across state lines. It addresses the impact of the Ryan Haight Act, the temporary waivers during the COVID-19 Public Health Emergency, and the DEA's subsequent proposed rules for a permanent telehealth prescribing framework.
The Centers for Medicare & Medicaid Services (CMS) has specific requirements for healthcare providers to credential and enroll in Medicare, which are critical for billing telehealth services. Understanding these rules, including temporary waivers and permanent flexibilities, is essential for compliant telehealth operations and reimbursement.
Interstate licensure compacts like IMLC, PSYPACT, and the ASWB Social Work Compact are streamlining multi-state practice for various healthcare professionals, enabling telehealth expansion while maintaining regulatory oversight. These compacts offer a pathway for licensed providers to practice across state lines without obtaining full, individual licenses in each participating jurisdiction.
The New Jersey State Board of Pharmacy has established clear regulations governing the dispensing, compounding, and fulfillment of prescriptions originating from telehealth encounters. These rules emphasize patient safety, proper prescription transmission, and adherence to compounding standards, directly impacting telehealth providers operating within or serving New Jersey residents.
The Drug Enforcement Administration (DEA) has issued proposed rules for the permanent prescribing of controlled substances via telehealth after the COVID-19 Public Health Emergency (PHE) flexibilities expire. These rules aim to balance patient access with preventing diversion, primarily requiring an in-person medical evaluation for Schedule II-V controlled substances before a telehealth prescription, with some exceptions.
Kentucky's Board of Pharmacy maintains specific regulations that govern the practice of pharmacy, including aspects relevant to telehealth prescribing, compounding, and medication fulfillment. These rules ensure patient safety and proper medication dispensing, requiring telehealth providers to understand the state's framework for valid prescriptions and pharmacy operations.
Telehealth providers prescribing controlled substances must adhere to DEA registration requirements, which are complicated by state lines and the Ryan Haight Act. While the COVID-19 public health emergency temporarily waived certain in-person examination requirements, the DEA is working towards a permanent framework, making understanding current and proposed rules critical for compliance.
Operating functional medicine and longevity programs via telehealth across state lines presents complex regulatory challenges, primarily concerning state-specific licensure, scope of practice, and the definition of a valid patient-provider relationship. Healthcare businesses must meticulously adhere to the laws of both the originating and receiving states to avoid compliance risks and potential enforcement actions. Understanding these nuances is critical for sustainable multi-state telehealth operations.
Comprehensive guides, checklists, and templates to help you navigate healthcare compliance — from CPOM structuring to GFE requirements and medical director agreements.
Everything you need to know about GFE requirements, best practices, and state-specific regulations.
Read guideComprehensive breakdown of Corporate Practice of Medicine laws across all 50 states.
Read guideThe definitive checklist for launching and maintaining compliant telehealth and in-person healthcare operations.
Read guideStep-by-step guide to structuring Professional Corporations and Management Services Organizations.
Read guideState-by-state requirements for medical director oversight in telehealth, medspas, IV therapy clinics, and other healthcare operations.
Read guideRegulatory requirements for GLP-1 weight loss medication prescribing via telehealth.
Read guideState-specific CPA templates and guidance for physician-NP collaborative arrangements.
Read guideOur AI-powered intelligence engine monitors DEA, DOJ, FDA, CMS, and all 50 state medical boards so you never miss a compliance update that affects your business.